跳至主要内容
临床试验/NCT00868348
NCT00868348已完成4 期

Local Infiltration Analgesia for Total Knee Arthroplasty: Should Ketorolac be Added

University of Aarhus1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2009年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
60
试验地点
1
主要终点
Morphine Consumption

研究概览

简要总结

The purpose of this study is to determine wether ketorolac is effective in the treatment of postoperative pain after total knee arthroplasty

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Total knee arthroplasty
  • Age > 18
  • Tolerance for study drugs
  • Written informed consent

排除标准

  • 未提供

研究组 & 干预措施

Ketorolac

Active Comparator

干预措施: Ketorolac (Drug)

Saline

Placebo Comparator

干预措施: Saline (Drug)

结局指标

主要结局

Morphine Consumption

时间窗: 48 hours after surgery

Consumption of intravenous (i.v.) patient-controlled analgesia (PCA) morphine during the first forty-eight hours after surgery

次要结局

  • Time to First i.v. Patient Controlled Analgesia (PCA) Morphine Request(within 48 hours after surgery)
  • Pain Intensity Scores During Walking(6-24 hours postoperatively)
  • Home Readiness(time to fulfilment of discharge criteria)
  • Length of Hospital Stay(From the day of surgery until discharge)
  • Pain Intensity During Daily Activity(16 weeks after surgery)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验